Pulse Biosciences Inc

3.39-0.0200-0.59%Vol 37.81K1Y Perf -69.55%
Feb 6th, 2023 16:00 DELAYED
BID3.35 ASK3.39
Open3.45 Previous Close3.41
Pre-Market- After-Market-
 - -  - -%
Target Price
5.00 
Analyst Rating
Hold 3.00
Potential %
47.49 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
+     36.54
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
20.76 
Earnings Rating
Sell
Market Cap126.20M 
Earnings Date
30th Mar 2023
Alpha-0.04 Standard Deviation0.23
Beta1.98 

Today's Price Range

3.263.45

52W Range

1.1811.83

5 Year PE Ratio Range

-7.50-9.00

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
8.31%
1 Month
19.79%
3 Months
62.20%
6 Months
113.21%
1 Year
-69.55%
3 Years
-75.29%
5 Years
-82.13%
10 Years
-

TickerPriceChg.Chg.%
PLSE3.39-0.0200-0.59
AAPL151.73-2.7700-1.79
GOOG103.47-1.7500-1.66
MSFT256.77-1.5800-0.61
XOM111.73-0.1900-0.17
WFC47.680.10000.21
JNJ163.36-1.2500-0.76
FB196.640.99000.51
GE82.350.39000.48
JPM141.920.83000.59
 
ProfitabilityValueIndustryS&P 500US Markets
-665.90
-4 167.50
-4 082.80
-
-
RevenueValueIndustryS&P 500US Markets
709.00K
0.02
-
-
Earnings HistoryEstimateReportedSurprise %
Q03 2022--0.48-
Q02 2022-0.37-0.43-16.22
Q01 2022-0.58-0.546.90
Q04 2021-0.62-0.5117.74
Q03 2021-0.59-0.4818.64
Q02 2021-0.88-0.5735.23
Q01 2021-0.79-0.7011.39
Q04 2020-0.45-0.54-20.00
Earnings Per EndEstimateRevision %Trend
9/2022 QR-0.310.00-
12/2022 QR-0.320.00-
12/2022 FY-1.528.43Positive
12/2023 FY-0.9229.77Positive
Next Report Date30th Mar 2023
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume37.81K
Shares Outstanding37.23K
Shares Float21.42M
Trades Count709
Dollar Volume126.35K
Avg. Volume66.17K
Avg. Weekly Volume40.58K
Avg. Monthly Volume73.23K
Avg. Quarterly Volume84.68K

Pulse Biosciences Inc (NASDAQ: PLSE) stock closed at 3.39 per share at the end of the most recent trading day (a -0.59% change compared to the prior day closing price) with a volume of 37.81K shares and market capitalization of 126.20M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 82 people. Pulse Biosciences Inc CEO is Darrin R. Uecker.

The one-year performance of Pulse Biosciences Inc stock is -69.55%, while year-to-date (YTD) performance is 22.38%. PLSE stock has a five-year performance of -82.13%. Its 52-week range is between 1.18 and 11.825, which gives PLSE stock a 52-week price range ratio of 20.76%

Pulse Biosciences Inc currently has a PE ratio of -1.40, a price-to-book (PB) ratio of 17.02, a price-to-sale (PS) ratio of 168.55, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -89.61%, a ROC of -91.81% and a ROE of -279.39%. The company’s profit margin is -%, its EBITDA margin is -4 082.80%, and its revenue ttm is $709.00 Thousand , which makes it $0.02 revenue per share.

Of the last four earnings reports from Pulse Biosciences Inc, there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Pulse Biosciences Inc’s next earnings report date is 30th Mar 2023.

The consensus rating of Wall Street analysts for Pulse Biosciences Inc is Hold (3), with a target price of $5, which is +47.49% compared to the current price. The earnings rating for Pulse Biosciences Inc stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Pulse Biosciences Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Pulse Biosciences Inc has a Buy technical analysis rating based on Technical Indicators (ADX : 25.97, ATR14 : 0.25, CCI20 : 74.77, Chaikin Money Flow : 0.22, MACD : 0.14, Money Flow Index : 37.26, ROC : 3.65, RSI : 60.32, STOCH (14,3) : 53.30, STOCH RSI : 1.00, UO : 46.38, Williams %R : -46.70), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Pulse Biosciences Inc in the last 12-months were: Darrin R. Uecker (Option Excercise at a value of $0), Kevin Danahy (Buy at a value of $14 950), Mahkam Zanganeh (Option Excercise at a value of $0), Mitchell E. Levinson (Buy at a value of $69 908), Mitchell E. Levinson (Option Excercise at a value of $0), Robert W. Duggan (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
3.00
Hold
3.00
Hold
3.00

Pulse Biosciences Inc

Pulse Biosciences Inc is a clinical-stage medical therapy company which pursues the commercial introduction of its proprietary CellFX System utilizing its patent-protected Nano-Pulse Stimulation (NPS) platform technology. Through its proprietary CellFX System, the company can deliver a cell-focused effect on dysfunctional cells while preserving surrounding non-cellular tissue, a combination that may potentially lead to both improved efficacy and less collateral tissue damage.

CEO: Darrin R. Uecker

Telephone: +1 510 906-4600

Address: 3957 Point Eden Way, Hayward 94545, CA, US

Number of employees: 82

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

45%55%

Bearish Bullish

55%45%

Bearish Bullish

61%39%

TipRanks News for PLSE

Sat, 12 Nov 2022 19:45 GMT Pulse Biosciences (PLSE) Gets a Hold from Maxim Group

- TipRanks. All rights reserved.

News

Stocktwits